
Krystal Biotech, Patient Impact Award
Send us Fan Mail A new episode of Being a Life Sciences Leader, honoring the 2023 Patient Impact Award recipient, is now available. In this episode, Krish Krishnan, Chairman & CEO, and Suma Krishnan, President of Research & Development, discuss Krystal Biotech's VYJUVEK - the first ever FDA approved redosable gene therapy.
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
